Only cPLA2 antagonist (Figure 4(b)) slightly increased the number of parasites/cell (P < 0.05) at 60 min after infection, but neither PPARβ/δ nor PPARγ agonists increased it; however, at 120 min after infection PPARβ/δ agonist slightly increased parasite burden (P < 0.05), but PPARγ agonist and cPLA2 inhibition decreased parasite burden significantly (P < 0.001) (Figure 4(b)). Here, PLA2G4A is linked to infection.